Food And Drug Administration
healthcare major sun pharmaceutical industries shares plunged 4.5 percent intraday wednesday as brokerage house iifl said the us health regulator has issued 14-page 483 observations letter after the inspection of halol unit, gujarat. the us food and drug administration has completed inspection
11.37 AM Dec 7th
hares of the drug maker rose 1.9 percent to Rs 1,547 after it announced that its U.S. subsidiary, Lupin Pharmaceuticals Inc., has received the final approval for marketing of Armodafinil tablets (50 mg, 150 mg, 200 mg and 250 mg) from the United States Food and Drug Administration.
1.59 PM Nov 30th
in 2009, the company sued india`s sun pharmaceutical industries ltd. for failing to disclose that the us food and drug administration (fda) had effectively closed down sun`s us subsidiary, in their legal battle over taro`s unilateral cancellation of the takeover contract by sun.
11.08 AM Nov 17th
Wockhardt has received EIR (establishment inspection report) for the Form 483 on the Waluj and Chikalthana plant from US Food and Drug Administration (USFDA) s Jan 15 visit. In our view, this raises chances of clearance of another pending 483 from USFDA s Feb 16 visit. We believe this should remove
4.28 PM Nov 5th
The Asian Age : US health regulator excluded one of its drugs - Ceftriazone Sodium - from import alert issued earlier against its active pharmaceutical ingredient manufacturing facility at Ankleshwar. The United States Food and Drug Administration (USFDA) on September 30, 2016 had posted on its
2.59 PM Nov 3rd
Cipla: Top Sensex Performer Shares of the drug maker rose 3.2 percent to Rs 599 after it received the Establishment Inspection Report from the U.S. Food and Drug Administration for its Indore facility. The company informed about it in a filing to the Bombay Stock Exchange. The report marks
10.29 AM Oct 14th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.